EXOZ earnings: real EPS beat/miss history, P/E -4.46. Updated 2026-07-23.
eXoZymes (EXOZ) Research Hub
eXoZymes (EXOZ) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 6.301 USD (+2.13%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -4.46, market cap 0.05B. This hub links to the full technical, earnings and options research available for EXOZ.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 6.301 USD (+2.13%) |
| 52-week range | 4.35 USD – 8.65 USD |
| Trend regime | Range |
| 14-day RSI | 62.9 (Bullish) |
| Trailing P/E | -4.46 |
| Market cap | 0.05B |
| Dividend yield | 0.00% |
Available research for EXOZ
Covered Call on EXOZ: how it works, illustrative setup around the real 6.3 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on EXOZ: how it works, illustrative setup around the real 6.3 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on EXOZ: how it works, illustrative setup around the real 6.3 USD price, max profit/loss, breakeven and when to use it. Educational.
EXOZ technical analysis: range, last 6.301 USD, RSI 62.9, 52w range 4.35 USD–8.65 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is EXOZ in?
eXoZymes (EXOZ) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is EXOZ in an uptrend or downtrend?
As of 2026-09-11, EXOZ is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is EXOZ's trailing P/E ratio?
EXOZ's trailing P/E is -4.46, with a market cap of 0.05B. See the earnings research page for full valuation detail.